SCHEMBL27202091

SCHEMBL27202091

CCCc1ccnnc1C(N)=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.34
SYK P43405 3/20 0.33
KCNH2 Q12809 3/20 0.33
PRKCI P41743 1/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP2E1 P05181 1/20 0.33
CYP2C8 P10632 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
MAP2K3 P46734 3/20 0.32
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22290178 0.87 P2RX7 (0.34) SYKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL21464721 0.87 BID (0.39) CYP3A4TSHRMEN1KMT2A
SCHEMBL3716799 0.76 KDM4E (0.45) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL7439674 0.75 IKBKB (0.39) IKBKBPRKCIKDM4EALDH1A1HPGD
SCHEMBL3955969 0.75 GABRP (0.41) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL7439410 0.75 KDM4E (0.38) IKBKBPRKCIKDM4ECYP2E1CYP2C8
SCHEMBL8600507 0.75 MKNK1 (0.41) SYKKCNH2KDM4EALDH1A1HPGD
SCHEMBL27202082 0.75 CCNA2 (0.32) IKBKBMAP2K3P2RX7MEN1KMT2A
SCHEMBL8909529 0.73 BID (0.38) ALDH1A1CYP3A4TSHRMEN1KMT2A
SCHEMBL21358990 0.72 NOS2 (0.40) KDM4ECYP2E1CYP2C8CYP2D6CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP MGMT, MCL1, FANCF IKBKB 1966/4885SYK 1397/4885KCNH2 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.